{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:24:48Z","timestamp":1766579088468,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-024-02287-3","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T13:13:48Z","timestamp":1731762828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Valproate Administration to Adult 5xFAD Mice Upregulates Expression of Neprilysin and Improves Olfaction and Memory"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0601-2358","authenticated-orcid":false,"given":"Dmitrii S.","family":"Vasilev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezhda M.","family":"Dubrovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia L.","family":"Tumanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr N.","family":"Tursunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-3540","authenticated-orcid":false,"given":"Natalia N.","family":"Nalivaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"2287_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jns.2012.08.028","volume":"323","author":"M Barresi","year":"2012","unstructured":"Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, Marino S (2012) Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci 323:16\u201324. https:\/\/doi.org\/10.1016\/j.jns.2012.08.028","journal-title":"J Neurol Sci"},{"key":"2287_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/embor.2008.222","volume":"10","author":"ND Belyaev","year":"2009","unstructured":"Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep 10:94\u2013100. https:\/\/doi.org\/10.1038\/embor.2008.222","journal-title":"EMBO Rep"},{"key":"2287_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13041-015-0110-5","volume":"8","author":"L Devi","year":"2015","unstructured":"Devi L, Ohno M (2015) A combination Alzheimer\u2019s therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice. Mol Brain 8:19. https:\/\/doi.org\/10.1186\/s13041-015-0110-5","journal-title":"Mol Brain"},{"key":"2287_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","volume":"8","author":"RL Doty","year":"2012","unstructured":"Doty RL (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8:329\u2013339. https:\/\/doi.org\/10.1038\/nrneurol.2012.80","journal-title":"Nat Rev Neurol"},{"key":"2287_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2353\/ajpath.2007.070105","volume":"171","author":"W Farris","year":"2007","unstructured":"Farris W, Sch\u00fctz SG, Cirrito JR, Shankar GM, Sun X, George A, Leissring MA, Walsh DM, Qiu WQ, Holtzman DM, Selkoe DJ (2007) Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol 171:241\u2013251. https:\/\/doi.org\/10.2353\/ajpath.2007.070105","journal-title":"Am J Pathol"},{"issue":"3","key":"2287_CR6","doi-asserted-by":"publisher","first-page":"e13032","DOI":"10.1111\/bpa.13032","volume":"32","author":"M Friesen","year":"2022","unstructured":"Friesen M, Ziegler-Waldkirch S, Egenolf M, d\u2019Errico P, Helm C, Mez\u00f6 C, Dokalis N, Erny D, Katzmarski N, Coelho R, Loreth D, Prinz M, Meyer-Luehmann M (2022) Distinct A\u03b2 pathology in the olfactory bulb and olfactory deficits in a mouse model of A\u03b2 and \u03b1-syn co-pathology. Brain Pathol 32(3):e13032. https:\/\/doi.org\/10.1111\/bpa.13032","journal-title":"Brain Pathol"},{"key":"2287_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12031-010-9460-8","volume":"43","author":"LR Hanson","year":"2011","unstructured":"Hanson LR, Hafez D, Svitak AL, Burns RB, Li X, Frey WH 2nd, Marr RA (2011) Intranasal phosphoramidon increases \u03b2-amyloid levels in wild-type and NEP\/NEP2-deficient mice. J Mol Neurosci 43:424\u2013427. https:\/\/doi.org\/10.1007\/s12031-010-9460-8","journal-title":"J Mol Neurosci"},{"key":"2287_CR8","doi-asserted-by":"publisher","unstructured":"H\u00fcttenrauch M, Baches S, Gerth J, Bayer TA, Weggen S, Wirths O (2015) Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease. J Alzheimers Dis 44:1291\u2013302. https:\/\/doi.org\/10.3233\/JAD-142463","DOI":"10.3233\/JAD-142463"},{"key":"2287_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/156720509789207949","volume":"6","author":"S Kalinin","year":"2009","unstructured":"Kalinin S, Richardson JC, Feinstein DL (2009) A PPAR\u03b3 agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer\u2019s disease. Curr Alzheimer Res 6:431\u2013437. https:\/\/doi.org\/10.2174\/156720509789207949","journal-title":"Curr Alzheimer Res"},{"key":"2287_CR10","doi-asserted-by":"publisher","first-page":"113304","DOI":"10.1016\/j.expneurol.2020.113304","volume":"329","author":"G Lane","year":"2020","unstructured":"Lane G, Zhou G, Noto T, Zelano C (2020) Assessment of direct knowledge of the human olfactory system. Exp Neurol 329:113304. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113304","journal-title":"Exp Neurol"},{"key":"2287_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262)","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262)","journal-title":"Methods"},{"key":"2287_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/cns.12445","volume":"21","author":"ZM Long","year":"2015","unstructured":"Long ZM, Zhao L, Jiang R, Wang KJ, Luo SF, Zheng M, Li XF, He GQ (2015) Valproic acid modifies synaptic structure and accelerates neurite outgrowth via the glycogen synthase kinase-3\u03b2 signaling pathway in an Alzheimer\u2019s disease model. CNS Neurosci Ther 21:887\u2013897. https:\/\/doi.org\/10.1111\/cns.12445","journal-title":"CNS Neurosci Ther"},{"key":"2287_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neubiorev.2021.02.024","volume":"125","author":"AM Lyons-Warren","year":"2021","unstructured":"Lyons-Warren AM, Herman I, Hunt PJ, Arenkiel BR (2021) A systematic-review of olfactory deficits in neurodevelopmental disorders: from mouse to human. Neurosci Biobehav Rev 125:110\u2013121. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.02.024","journal-title":"Neurosci Biobehav Rev"},{"key":"2287_CR14","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1523\/JNEUROSCI.23-06-01992.2003","volume":"23","author":"RA Marr","year":"2003","unstructured":"Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, Verma IM, Masliah E (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 23:1992\u20131996. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-06-01992.2003","journal-title":"J Neurosci"},{"key":"2287_CR15","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.cub.2021.01.066","volume":"31","author":"M Midroit","year":"2021","unstructured":"Midroit M, Chalen\u00e7on L, Renier N, Milton A, Thevenet M, Sacquet J, Breton M, Forest J, Noury N, Richard M, Raineteau O, Ferdenzi C, Fournel A, Wesson DW, Bensafi M, Didier A, Mandairon N (2021) Neural processing of the reward value of pleasant odorants. Curr Biol 31:1592-1605.e9. https:\/\/doi.org\/10.1016\/j.cub.2021.01.066","journal-title":"Curr Biol"},{"key":"2287_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0023-9690(81)90020-5","volume":"12","author":"RGM Morris","year":"1981","unstructured":"Morris RGM (1981) Spatial localization does not require the presence of local cues. Learn Motiv 12:239\u2013260. https:\/\/doi.org\/10.1016\/0023-9690(81)90020-5","journal-title":"Learn Motiv"},{"key":"2287_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbr.2005.10.014","volume":"168","author":"A Mouri","year":"2006","unstructured":"Mouri A, Zou LB, Iwata N, Saido TC, Wang D, Wang MW, Noda Y, Nabeshima T (2006) Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid \u03b2 and impairment of learning and memory. Behav Brain Res 168:83\u201391. https:\/\/doi.org\/10.1016\/j.bbr.2005.10.014","journal-title":"Behav Brain Res"},{"key":"2287_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41582-018-0097-5","volume":"15","author":"C Murphy","year":"2019","unstructured":"Murphy C (2019) Olfactory and other sensory impairments in Alzheimer disease. Nat Rev Neurol 15:11\u201324. https:\/\/doi.org\/10.1038\/s41582-018-0097-5","journal-title":"Nat Rev Neurol"},{"key":"2287_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1365-2826.2011.02196.x","volume":"23","author":"EK Murray","year":"2011","unstructured":"Murray EK, Varnum MM, Fernandez JL, de Vries GJ, Forger NG (2011) Effects of neonatal treatment with valproic acid on vasopressin immunoreactivity and olfactory behaviour in mice. J Neuroendocrinol 23:906\u2013914. https:\/\/doi.org\/10.1111\/j.1365-2826.2011.02196.x","journal-title":"J Neuroendocrinol"},{"key":"2287_CR20","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1111\/bph.14593","volume":"176","author":"NN Nalivaeva","year":"2019","unstructured":"Nalivaeva NN, Turner AJ (2019) Targeting amyloid clearance in Alzheimer\u2019s disease as a therapeutic strategy. Br J Pharmacol 176:3447\u20133463. https:\/\/doi.org\/10.1111\/bph.14593","journal-title":"Br J Pharmacol"},{"key":"2287_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12031-011-9644-x","volume":"46","author":"NN Nalivaeva","year":"2012","unstructured":"Nalivaeva NN, Belyaev ND, Lewis DI, Pickles AR, Makova NZ, Bagrova DI, Dubrovskaya NM, Plesneva SA, Zhuravin IA, Turner AJ (2012) Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J Molecular Neurosci 46:569\u2013577. https:\/\/doi.org\/10.1007\/s12031-011-9644-x","journal-title":"J Molecular Neurosci"},{"key":"2287_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fnagi.2014.00235","volume":"6","author":"NN Nalivaeva","year":"2014","unstructured":"Nalivaeva NN, Belyaev ND, Kerridge C, Turner AJ (2014) Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer\u2019s disease. Front Aging Neurosci 6:235. https:\/\/doi.org\/10.3389\/fnagi.2014.00235","journal-title":"Front Aging Neurosci"},{"key":"2287_CR23","doi-asserted-by":"publisher","first-page":"111363","DOI":"10.1016\/j.mad.2020.111363","volume":"192","author":"NN Nalivaeva","year":"2020","unstructured":"Nalivaeva NN, Zhuravin IA, Turner AJ (2020) Neprilysin expression and functions in development, ageing and disease. Mech Ageing Dev 192:111363. https:\/\/doi.org\/10.1016\/j.mad.2020.111363","journal-title":"Mech Ageing Dev"},{"key":"2287_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnbeh.2019.00061","volume":"13","author":"S Nocera","year":"2019","unstructured":"Nocera S, Simon A, Fiquet O, Chen Y, Gascuel J, Datiche F, Schneider N, Epelbaum J, Viollet C (2019) Somatostatin serves a modulatory role in the mouse olfactory bulb: neuroanatomical and behavioral evidence. Front Behav Neurosci 13:61. https:\/\/doi.org\/10.3389\/fnbeh.2019.00061","journal-title":"Front Behav Neurosci"},{"key":"2287_CR25","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"HO Oakley","year":"2006","unstructured":"Oakley HO, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26:10129\u201310140. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-06.2006","journal-title":"J Neurosci"},{"key":"2287_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/ijms25010390","volume":"25","author":"A Ornoy","year":"2024","unstructured":"Ornoy A, Echefu B, Becker M (2024) Valproic acid in pregnancy revisited: neurobehavioral, biochemical and molecular changes affecting the embryo and fetus in humans and in animals: a narrative review. Int J Mol Sci 25:390. https:\/\/doi.org\/10.3390\/ijms25010390","journal-title":"Int J Mol Sci"},{"key":"2287_CR27","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.3390\/ijms25126766","volume":"25","author":"MS P\u00e1dua","year":"2024","unstructured":"P\u00e1dua MS, Guil-Guerrero JL, Lopes PA (2024) Behaviour hallmarks in Alzheimer\u2019s disease 5xFAD mouse model. Int J Mol Sci 25:6766. https:\/\/doi.org\/10.3390\/ijms25126766","journal-title":"Int J Mol Sci"},{"key":"2287_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JHD-210497","volume":"10","author":"J Patino","year":"2021","unstructured":"Patino J, Karagas NE, Chandra S, Thakur N, Stimming EF (2021) Olfactory dysfunction in Huntington\u2019s disease. J Huntingtons Dis 10:413\u2013422. https:\/\/doi.org\/10.3233\/JHD-210497","journal-title":"J Huntingtons Dis"},{"key":"2287_CR29","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego","edition":"2"},{"key":"2287_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/B978-0-444-63855-7.00024-1","volume":"164","author":"RD Prediger","year":"2019","unstructured":"Prediger RD, Schamne MG, Sampaio TB, Moreira ELG, Rial D (2019) Animal models of olfactory dysfunction in neurodegenerative diseases. Handb Clin Neurol 164:431\u2013452. https:\/\/doi.org\/10.1016\/B978-0-444-63855-7.00024-1","journal-title":"Handb Clin Neurol"},{"key":"2287_CR31","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"H Qing","year":"2008","unstructured":"Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z, Wei S, Sun X, Chen CH, Zhou W, Wang K, Song W (2008) Valproic acid inhibits A\u03b2 production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models. J Exp Med 205:2781\u20132789. https:\/\/doi.org\/10.1084\/jem.20081588","journal-title":"J Exp Med"},{"key":"2287_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3233\/JAD-220075","volume":"88","author":"L Ramirez-Gomez","year":"2022","unstructured":"Ramirez-Gomez L, Albers MW, Baena A, Vila-Castelar C, Fox-Fuller JT, Sanchez J, Jain F, Albers AD, Lopera F, Quiroz YT (2022) Olfactory function and markers of brain pathology in non-demented individuals with autosomal dominant Alzheimer\u2019s disease. J Alzheimers Dis 88:721\u2013729. https:\/\/doi.org\/10.3233\/JAD-220075","journal-title":"J Alzheimers Dis"},{"key":"2287_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/chemse\/bjw018","volume":"41","author":"KM Roddick","year":"2016","unstructured":"Roddick KM, Roberts AD, Schellinck HM, Brown RE (2016) Sex and genotype differences in odor detection in the 3Tg-AD and 5XFAD mouse models of Alzheimer\u2019s disease at 6 months of age. Chem Senses 41:433\u2013440. https:\/\/doi.org\/10.1093\/chemse\/bjw018","journal-title":"Chem Senses"},{"key":"2287_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","volume":"17","author":"M Romoli","year":"2019","unstructured":"Romoli M, Mazzocchetti P, D\u2019Alonzo R, Siliquini S, Rinaldi VE, Verrotti A, Calabresi P, Costa C (2019) Valproic acid and epilepsy: from molecular mechanisms to clinical evidences. Curr Neuropharmacol 17:926\u2013946. https:\/\/doi.org\/10.2174\/1570159X17666181227165722","journal-title":"Curr Neuropharmacol"},{"key":"2287_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nm1206","volume":"11","author":"T Saito","year":"2005","unstructured":"Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, Suemoto T, Higuchi M, Saido TC (2005) Somatostatin regulates brain amyloid beta peptide A\u03b242 through modulation of proteolytic degradation. Nat Med 11:434\u2013439. https:\/\/doi.org\/10.1038\/nm1206","journal-title":"Nat Med"},{"key":"2287_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.expneurol.2009.06.010","volume":"223","author":"D Saiz-Sanchez","year":"2010","unstructured":"Saiz-Sanchez D, Ubeda-Ba\u00f1on I, de la Rosa-Prieto C, Argando\u00f1a-Palacios L, Garcia-Mu\u00f1ozguren S, Insausti R, Martinez-Marcos A (2010) Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease. Exp Neurol 223:347\u2013350. https:\/\/doi.org\/10.1016\/j.expneurol.2009.06.010","journal-title":"Exp Neurol"},{"key":"2287_CR37","doi-asserted-by":"publisher","first-page":"21895","DOI":"10.1074\/jbc.M008511200","volume":"276","author":"K Shirotani","year":"2001","unstructured":"Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo S, Kiyama H, Iwata H, Tomita T, Iwatsubo T, Saido TC (2001) Neprilysin degrades both amyloid \u03b2 peptides 1\u201340 and 1\u201342 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276:21895\u201321901. https:\/\/doi.org\/10.1074\/jbc.M008511200","journal-title":"J Biol Chem"},{"key":"2287_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fnins.2016.00207","volume":"10","author":"S Sun","year":"2016","unstructured":"Sun S, Li T, Davies H, Li W, Yang J, Li S, Ling S (2016) Altered morphologies and functions of the olfactory bulb and hippocampus induced by miR-30c. Front Neurosci 10:207. https:\/\/doi.org\/10.3389\/fnins.2016.00207","journal-title":"Front Neurosci"},{"key":"2287_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.scr.2014.10.001","volume":"13","author":"K Takamatsu","year":"2014","unstructured":"Takamatsu K, Ikeda T, Haruta M, Matsumura K, Ogi Y, Nakagata N, Uchino M, Ando Y, Nishimura Y, Senju S (2014) Degradation of amyloid \u03b2 by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Res 13:442\u2013453. https:\/\/doi.org\/10.1016\/j.scr.2014.10.001","journal-title":"Stem Cell Res"},{"key":"2287_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/s1474-4422(15)00314-2","volume":"15","author":"T Tomson","year":"2016","unstructured":"Tomson T, Battino D, Perucca E (2016) Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol 15:210\u2013218. https:\/\/doi.org\/10.1016\/s1474-4422(15)00314-2","journal-title":"Lancet Neurol"},{"key":"2287_CR41","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1134\/S0022093022040251","volume":"58","author":"NL Tumanova","year":"2022","unstructured":"Tumanova NL, Vasilev DS, Dubrovskaya NM, Nalivaeva NN (2022) Neurodegenerative changes in the structural and ultrastructural organization in the pyriform cortex of 5xFAD transgenic mice. J Evol Biochem Phys 58:1225\u20131239. https:\/\/doi.org\/10.1134\/S0022093022040251","journal-title":"J Evol Biochem Phys"},{"key":"2287_CR42","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.31857\/S0869813923100126","volume":"109","author":"AN Tursunov","year":"2023","unstructured":"Tursunov AN, Vasilyev DS, Nalivaeva NN (2023) Molecular mechanisms of valproic acid action on signalling systems and brain functions. Ross Fiziol Zh Im IM Sechenova 109:1331\u20131348. https:\/\/doi.org\/10.31857\/S0869813923100126","journal-title":"Ross Fiziol Zh Im IM Sechenova"},{"key":"2287_CR43","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s12031-020-01786-3","volume":"71","author":"DS Vasilev","year":"2021","unstructured":"Vasilev DS, Dubrovskaya NM, Zhuravin IA, Nalivaeva NN (2021) Developmental profile of brain neprilysin expression correlates with olfactory behaviour of rats. J Mol Neurosci 71:1772\u20131785. https:\/\/doi.org\/10.1007\/s12031-020-01786-3","journal-title":"J Mol Neurosci"},{"key":"2287_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1134\/S0022093022010173","volume":"58","author":"DS Vasilev","year":"2022","unstructured":"Vasilev DS, Dubrovskaya NM, Tumanova NL, Nalivaeva NN (2022) Analysis of expression of the amyloid-degrading enzyme neprilysin in brain structures of 5xFAD transgenic mice. J Evol Biochem Phys 58:193\u2013203. https:\/\/doi.org\/10.1134\/S0022093022010173","journal-title":"J Evol Biochem Phys"},{"key":"2287_CR45","doi-asserted-by":"publisher","first-page":"1198267","DOI":"10.3389\/fnins.2023.1198267","volume":"17","author":"BJ Vilarello","year":"2023","unstructured":"Vilarello BJ, Jacobson PT, Tervo JP, Waring NA, Gudis DA, Goldberg TE, Devanand DP, Overdevest JB (2023) Olfaction and neurocognition after COVID-19: a scoping review. Front Neurosci 17:1198267. https:\/\/doi.org\/10.3389\/fnins.2023.1198267","journal-title":"Front Neurosci"},{"key":"2287_CR46","doi-asserted-by":"publisher","unstructured":"Watamura N, Kakiya N, Fujioka R, Kamano N, Takahashi M, Nilsson P, Saito T, Iwata N, Fujisawa S, Saido TC (2024) The dopaminergic system promotes neprilysin-mediated degradation of amyloid-\u03b2 in the brain. Sci Signal 17(848):eadk1822. https:\/\/doi.org\/10.1126\/scisignal.adk1822","DOI":"10.1126\/scisignal.adk1822"},{"key":"2287_CR47","doi-asserted-by":"publisher","first-page":"e0307154","DOI":"10.1371\/journal.pone.0307154","volume":"19","author":"A Watson","year":"2024","unstructured":"Watson A, Shah P, Lee D, Liang S, Joshi G, Metitiri E, Chowdhury WH, Bacich D, Dube P, Xiang Y, Hanley D, Martinez-Sobrido L, Rodriguez R (2024) Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: epidemiologic and in vitro analysis reveal mechanistic insights. PLoS One 19:e0307154. https:\/\/doi.org\/10.1371\/journal.pone.0307154","journal-title":"PLoS One"},{"key":"2287_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","volume":"51","author":"AG Xuan","year":"2015","unstructured":"Xuan AG, Pan XB, Wei P, Ji WD, Zhang WJ, Liu JH, Hong LP, Chen WL, Long DH (2015) Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer\u2019s disease. Mol Neurobiol 51:300\u2013312. https:\/\/doi.org\/10.1007\/s12035-014-8751-4","journal-title":"Mol Neurobiol"},{"key":"2287_CR49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/1570159X22666231003121513","volume":"22","author":"D Zarate-Lopez","year":"2024","unstructured":"Zarate-Lopez D, Torres-Ch\u00e1vez AL, G\u00e1lvez-Contreras AY, Gonzalez-Perez O (2024) Three decades of valproate: a current model for studying autism spectrum disorder. Curr Neuropharmacol 22:260\u2013289. https:\/\/doi.org\/10.2174\/1570159X22666231003121513","journal-title":"Curr Neuropharmacol"},{"key":"2287_CR50","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11064-019-02796-3","volume":"44","author":"IA Zhuravin","year":"2019","unstructured":"Zhuravin IA, Dubrovskaya NM, Vasilev DS, Kozlova DI, Kochkina EG, Tumanova NL, Nalivaeva NN (2019) Regulation of neprilysin activity and cognitive functions in rats after prenatal hypoxia. Neurochem Res 44:1387\u20131398. https:\/\/doi.org\/10.1007\/s11064-019-02796-3","journal-title":"Neurochem Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-024-02287-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-024-02287-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-024-02287-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T04:39:20Z","timestamp":1735965560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-024-02287-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2287"],"URL":"https:\/\/doi.org\/10.1007\/s12031-024-02287-3","relation":{},"ISSN":["1559-1166"],"issn-type":[{"type":"electronic","value":"1559-1166"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were carried out in accordance with the international guidelines for work with experimental animals based on the European Community directive on the humane treatment of experimental animals (Directive #86 \u2044 609 for the Care of Laboratory Animals) and NIH Guidelines for the care and use of laboratory animals ( index.htm) and were approved by the Scientific Ethical Council of the Institute of Evolutionary Physiology and Biochemistry RAS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors read and agreed to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"110"}}